Next Article in Journal
Development of a Larval Zebrafish Model for Acute Organophosphorus Nerve Agent and Pesticide Exposure and Therapeutic Evaluation
Previous Article in Journal
Lethal and Sublethal Effects of Pyriproxyfen on Apis and Non-Apis Bees
Previous Article in Special Issue
Effects of 3-Month Exposure to E-Cigarette Aerosols on Glutamatergic Receptors and Transporters in Mesolimbic Brain Regions of Female C57BL/6 Mice
Review

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

1
Department of Bromatology, Poznan University of Medical Sciences, 60-354 Poznan, Poland
2
Laboratory of Environmental Research, Department of Toxicology, Poznan University of Medical Sciences, 60-631 Poznan, Poland
*
Author to whom correspondence should be addressed.
Toxics 2020, 8(4), 105; https://doi.org/10.3390/toxics8040105
Received: 8 September 2020 / Revised: 10 November 2020 / Accepted: 16 November 2020 / Published: 17 November 2020
(This article belongs to the Special Issue Current Knowledge of E-cigarettes and Heated Tobacco Products)
The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic. View Full-Text
Keywords: electronic cigarettes; metabolic syndrome; insulin resistance; dyslipidemia; obesity electronic cigarettes; metabolic syndrome; insulin resistance; dyslipidemia; obesity
MDPI and ACS Style

Górna, I.; Napierala, M.; Florek, E. Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review. Toxics 2020, 8, 105. https://doi.org/10.3390/toxics8040105

AMA Style

Górna I, Napierala M, Florek E. Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review. Toxics. 2020; 8(4):105. https://doi.org/10.3390/toxics8040105

Chicago/Turabian Style

Górna, Ilona, Marta Napierala, and Ewa Florek. 2020. "Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review" Toxics 8, no. 4: 105. https://doi.org/10.3390/toxics8040105

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop